National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them clinically. Successful early-stage trials of new drugs from this NOFO would transition seamlessly to later stage trials using well-established NCI clinical trial mechanisms.
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for Centers within the NIDDK Cooperative Centers of Experimental in Hematology (CCEH) Program. Each Center will support one to three Biomedical Research…
Award
Not Announced
3 days leftcloses Sep 30, 2026
This program supports eligible applicants to facilitate collaborative planning and implementation of evidence-based cancer surveillance, prevention, and control strategies in communities. It aims to improve clinical preventive services and…
Award
Not Announced
About 4 months leftcloses Feb 5, 2027
The purpose of component A (8-11 awardees) of this NOFO is to collect high-quality longitudinal data on children and adults with spina bifida (SB) who receive care in specialized spina bifida clinics participating in the National Spina…
Award
$100.0K – $300.0K
29 days leftcloses Oct 26, 2026
A trauma system is an organized, inclusive approach to facilitating and coordinating a multidisciplinary system response to severely injured patients. Coordination across prehospital entities and hospitals signals an effective trauma…
Award
$300.0K – $500.0K
ClosedSep 18, 2026